Thomas Kislinger

Has grant

Professor

University of Toronto

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Cancer Biology Cancer Biology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Thomas Kislinger is a Professor at the University of Toronto in Canada. His research focuses on proteomics and metabolomics, with recent publications exploring non-canonical peptides, cancer cell models, and Alzheimer's disease. He has contributed significantly to the understanding of biomarkers in various cancers and the structural proteome of disease models.

Recent Grants

Grant: Close

Proteogenomics Panorama of Localized Prostate Cancers

Open Date: 2018-04-01

Close Date: 2021-03-31

Grant: Close

Identifying the molecular landscape of the triple negative breast cancer cell surface proteome – an avenue for new therapies

Open Date: 2018-02-01

Close Date: 2021-06-01

Grant: Close

The clinico-genomics of localized prostate cancer

Open Date: 2018-02-01

Close Date: 2023-01-31

Grant: Close

Interrogating radioresistance in prostate cancer: leveraging combined genomic and proteomic analyses

Open Date: 2017-07-01

Close Date: 2019-06-30

Grant: Close

Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer

Open Date: 2016-09-15

Close Date: 2021-08-31

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (13)

Magnus Palmblad

Associate Professor

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

Yiyang Liu

The Francis Crick Institute

UNITED KINGDOM

View details

Curtis W. McCloskey

Assistant Professor

UPMC Hillman Cancer Center

UNITED STATES

View details

Caroline Chen

University of California, Los Angeles

UNITED STATES

View details

Jason Moffat

Senior Scientist and Program Head

Hospital for Sick Children

CANADA

View details

John Yates

Professor

Scripps Research Institute

UNITED STATES

View details

Andrew Gao

University Health Network

CANADA

View details

Namita Sinha

Shared Health Manitoba

CANADA

View details

Roni Haas

David Geffen School of Medicine at UCLA

UNITED STATES

View details

Uwe Völker

Porf, Head of Department

Universitätsmedizin Greifswald

GERMANY

View details

Hong Han

Assistant Professor

McMaster University

CANADA

View details

Peter Gmeiner

Professor

Friedrich-Alexander Universität Erlangen-Nürnberg

GERMANY

View details

Ian Mills

University of Oxford

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Thomas Kislinger

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

A Novel Primary Cell Line Model of Localized Prostate Cancer and Radioresistance—A Role for Nicotinamide N-Methyltransferase

Proteomic and Metabolomic Data Transparency

Identification of non-canonical peptides with moPepGen

Multi-Omics Study Reveals Nc886/vtRNA2-1 as a Positive Regulator of Prostate Cancer Cell Immunity

Unveiling the structural proteome of an Alzheimer’s disease rat brain model

Organelle resolved proteomics uncovers PLA2R1 as a novel cell surface marker required for chordoma growth

Protocol for generating high-fidelity proteomic profiles using DROPPS

Droplet-based proteomics reveals CD36 as a marker for progenitors in mammary basal epithelium

Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma

Phosphoproteomic Analysis of Dopamine D2 Receptor Signaling Reveals Interplay of G Protein- and β-Arrestin-Mediated Effects

Proteomics of High-Grade Serous Ovarian Cancer Models Identifies Cancer-Associated Fibroblast Markers Associated with Clinical Outcomes

Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells

DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.

Optimization of small extracellular vesicle isolation from expressed prostatic secretions in urine for in-depth proteomic analysis.

CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment.

Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry

Spatially confined sub-tumor microenvironments in pancreatic cancer.

A proteomic investigation of isogenic radiation resistant prostate cancer cell lines

A clinically applicable integrative molecular classification of meningiomas.

Collaborators (13)

Magnus Palmblad

Yiyang Liu

Curtis W. McCloskey

Caroline Chen

Jason Moffat

John Yates

Andrew Gao

Namita Sinha

Roni Haas

Uwe Völker

Hong Han

Peter Gmeiner

Ian Mills

Make your next move.